Mesa, Mays Cancer Center play role in getting new medications for blood cancers approved
November 29, 2021
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 29, 2021) — With U.S. Food and Drug Administration (FDA) approval in November of a new medication for polycythemia vera (PV), the outlook brightened a bit for patients with that controllable, but chronic, form of blood cancer. Ruben A. Mesa, MD, FACP, executive director of the […]
